Proposals accepted until November 1st!
SLAS Discovery Guest Editors Peter Hodder, Ph.D., (Executive Director of Discovery Research, Amgen) and Mark Wigglesworth, Ph.D., (Director High Throughput Screening, AstraZeneca) invite the submission of abstracts that describe best-practice implementation of hit discovery technologies for publication in a 2021 Special Issue. Manuscript proposals (abstracts) will be used to select and invite papers for review and publication consideration.
Drs. Hodder and Wigglesworth seek high-quality, short- or full-length research reports, reviews, and perspectives related to impactful screening paradigms, plate-based assay and automation platforms, and related analyses of screening results. Manuscript proposals (abstracts) are welcome from academia, industry, and vendors. Areas of particular interest include, but are not limited to:
Submit your manuscript proposal before November 1, 2019. It should include your name, contact information, affiliation, a working title and abstract (250-500 words) as an MS Word document.
Invited manuscripts will need to be completed and submitted by March 31, 2020. All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Discovery special issue. Submissions from SLAS members, nonmembers and especially attendees of the Advanced 3D Human Models and High-Content Analysis Symposium, and AI in Process Automation Symposia are welcomed!
Publication note: After submissions are accepted, they typically publish online ahead-of-print within 30 days and become immediately searchable and citable with a DOI.
Questions? Please e-mail email@example.com or call +1.630.256.7527, ext. 106.